|
Analysis 1
|
|
Pre-treatment, n = 103
|
45/103 (44)
|
37/103 (36)
|
21/103 (20)
|
|
Control, n = 39
|
22/39 (56)
|
16/39 (41)
|
1/39 (3)
|
|
p value
|
0.1920
|
0.6978
|
0.0081
|
|
Analysis 2
|
|
Pre-treatment, n = 103
|
45/103 (44)
|
37/103 (36)
|
21/103 (20)
|
|
Post-treatment, n = 103
|
40/103 (39)
|
44/103 (43)
|
19/103 (18)
|
|
p value
|
0.5715
|
0.3922
|
0.8604
|
|
Analysis 3
|
|
Post-treatment, n = 103
|
40/103 (39)
|
44/103 (43)
|
19/103 (18)
|
|
Control, n = 39
|
22/39 (56)
|
16/39 (41)
|
1/39 (3)
|
|
p value
|
0.0873
|
1.000
|
0.0142
|
|
Sub-group analysis 3A
|
|
Post-treatment, normal cytology, n = 81
|
32/81 (40)
|
35/81 (43)
|
14/81 (17)
|
|
Control, n = 39
|
22/39 (56)
|
16/39 (41)
|
1/39 (3)
|
|
p value
|
0.1166
|
0.8463
|
0.0354
|
|
Sub-group analysis 3B
|
|
Post-treatment, normal cytology, HPV-negative, n = 70
|
27/70 (38)
|
30/70 (43)
|
13/70 (19)
|
|
Control, HPV negative, n = 23
|
12/23 (52)
|
10/23 (44)
|
1/23 (4)
|
|
p value
|
0.3309
|
1.0000
|
0.1758
|
